Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cequa for Biometry Accuracy in Dry Eye
NCT04342988Phase 4Completed
- Sponsor
- Research Insight
- Start
- Apr 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ciclosporin in dry eye syndrome (DED), sponsored by Research Insight. Primary endpoint: Spherical equivalent prediction error of pre-Cequa vs post-Cequa ocular biometry performed for cataract surgery at 4 weeks. Started Apr 2020; status: completed.
02
Drugs
ciclosporin
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT04342988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04342988.